Articles about Adar Poonawalla

Only faster COVID-19 vaccinations can end pandemic: Adar Poonawalla

19 Jan 2022

India
Only faster COVID-19 vaccinations can end pandemic: Adar Poonawalla

Billions need to be vaccinated at a faster rate to reach the end of the COVID-19 pandemic, said Adar Poonawalla, CEO of the Serum Institute of India (SII), which manufactures the COVID-19 vaccine Covishield.

SII to launch COVID-19 vaccine for children in 6 months

15 Dec 2021

India
SII to launch COVID-19 vaccine for children in 6 months

The Serum Institute of India is looking to launch a COVID-19 vaccine for children in six months, SII CEO Adar Poonawalla said Tuesday.

EU body says it didn't receive application for Covishield approval

17 Jul 2021

India
EU body says it didn't receive application for Covishield approval

The European Medicines Agency (EMA) said it has not received any application for the authorization of the coronavirus vaccine Covishield.

Serum to begin Covovax trials on children in July

26 Jun 2021

India
Serum to begin Covovax trials on children in July

The Serum Institute of India (SII) will soon apply for regulatory approval to conduct clinical trials of Covovax on children in India.

Covovax India launch by September; trial for kids soon: SII

17 Jun 2021

India
Covovax India launch by September; trial for kids soon: SII

The Serum Institute of India (SII) is looking to launch the COVID-19 vaccine developed by the United States firm Novavax in India by September.

Reports claiming fresh COVID-19 vaccine orders not placed baseless: Government

03 May 2021

India
Reports claiming fresh COVID-19 vaccine orders not placed baseless: Government

The Union Health Ministry on Monday refuted media reports that claimed that the central government had not placed fresh orders for COVID-19 vaccines.

Getting aggressive calls from powerful people: SII CEO Adar Poonawalla

02 May 2021

India
Getting aggressive calls from powerful people: SII CEO Adar Poonawalla

Serum Institute of India CEO Adar Poonawalla has revealed that his decision to fly to London when India is facing a COVID-19 second wave was largely due to the threats he had been facing.

Covishield price reduced to Rs. 300 for states: Adar Poonawalla

28 Apr 2021

India
Covishield price reduced to Rs. 300 for states: Adar Poonawalla

Adar Poonawalla, the CEO of the Serum Institute of India (SII), on Wednesday announced that the price of the COVID-19 vaccine Covishield was being reduced from Rs. 400 to Rs. 300 for states.

COVID-19 vaccine production hit as US, Europe obstruct raw material

15 Apr 2021

World
COVID-19 vaccine production hit as US, Europe obstruct raw material

As India faces a record surge in coronavirus infections, Serum Institute of India (SII) CEO Adar Poonawalla has raised concerns about the United States and Europe holding back key vaccine raw material.

AstraZeneca serves legal notice to Serum Institute over vaccine delays

08 Apr 2021

World
AstraZeneca serves legal notice to Serum Institute over vaccine delays

Serum Institute of India (SII), the manufacturer of the coronavirus vaccine Covishield, has been served a legal notice by the drug maker AstraZeneca over delays in vaccine supply, the company's CEO Adar Poonawalla confirmed in an interview earlier this week.

Covishield 90% effective if doses given 2-3 months apart: Poonawalla

06 Apr 2021

India
Covishield 90% effective if doses given 2-3 months apart: Poonawalla

The efficacy of the COVID-19 vaccine Covishield could increase to 90% if the two doses are given 2.5-3 months apart, Serum Institute of India CEO Adar Poonawalla said Monday.

Serum CEO Poonawalla hopes to launch second vaccine by September

27 Mar 2021

India
Serum CEO Poonawalla hopes to launch second vaccine by September

Serum Institute of India CEO Adar Poonawalla today said that his company hopes to launch its second coronavirus vaccine by September this year.

Adar Poonawalla, WHO scientist warn of delays in vaccine production

05 Mar 2021

World
Adar Poonawalla, WHO scientist warn of delays in vaccine production

Adar Poonawalla, the head of the world's biggest vaccine maker, and the World Health Organization's (WHO) chief scientist have said that the manufacturers of coronavirus vaccine doses are facing a global shortage of the raw materials required to produce the doses.

After SII fire, BCG, rotavirus vaccine production to be hit

22 Jan 2021

India
After SII fire, BCG, rotavirus vaccine production to be hit

Thursday's fire at Pune's Serum Institute of India will impact the production of BCG and rotavirus vaccines in the future, the company said on Friday.

Five killed in Serum Institute fire; Maharashtra government orders probe

21 Jan 2021

India
Five killed in Serum Institute fire; Maharashtra government orders probe

The Maharashtra government has ordered a probe into the fire that broke out at the Serum Institute of India in Pune on Thursday, killing at least five people.

Pune: Fire breaks out at Serum Institute of India

21 Jan 2021

India
Pune: Fire breaks out at Serum Institute of India

On Thursday afternoon, a fire broke out at the Terminal 1 gate of Serum Institute of India, Pune.

Rs. 200 per vaccine dose: SII receives government's purchase order

11 Jan 2021

India
Rs. 200 per vaccine dose: SII receives government's purchase order

The Pune-based Serum Institute of India (SII) has received the purchase order for COVID-19 vaccines from the central government, officials said on Monday.

Coronavirus vaccine consignment awaits government nod for take-off from Pune

08 Jan 2021

India
Coronavirus vaccine consignment awaits government nod for take-off from Pune

On Thursday night, the Pune Airport was prepared to airlift vials of coronavirus vaccine, the first such exercise in India's massive inoculation drive.

Sleeves up! Coronavirus vaccination drive could begin on January 13

05 Jan 2021

India
Sleeves up! Coronavirus vaccination drive could begin on January 13

The first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.

SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

05 Jan 2021

India
SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.

Private hospitals may get coronavirus vaccine by March: Serum CEO

04 Jan 2021

India
Private hospitals may get coronavirus vaccine by March: Serum CEO

While the Indian government has prioritized healthcare workers and high-risk individuals in its vaccine program, doses of the coronavirus vaccine will be available for private companies, hospitals, and individuals by as early as March, the CEO of Serum Institute of India (SII), Adar Poonawalla, said on Sunday.

'Finally paid off,' says Adar Poonawalla after Covishield gets approval

03 Jan 2021

India
'Finally paid off,' says Adar Poonawalla after Covishield gets approval

Serum Institute of India's (SII) chief Adar Poonawalla today wished everyone a happy new year along with a great announcement.

All you need to know about vaccines approved in India

03 Jan 2021

India
All you need to know about vaccines approved in India

Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.

India set to start COVID-19 vaccination; panel approves Oxford vaccine

01 Jan 2021

India
India set to start COVID-19 vaccination; panel approves Oxford vaccine

In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.

Centre extends COVID-19 surveillance guidelines till January 31

28 Dec 2020

India
Centre extends COVID-19 surveillance guidelines till January 31

The Ministry of Home Affairs on Monday extended guidelines for COVID-19 surveillance, containment, and caution till January 31, 2021.

Modi to chair all-party meet to review COVID-19 situation Friday

30 Nov 2020

India
Modi to chair all-party meet to review COVID-19 situation Friday

Prime Minister Narendra Modi is set to chair an all-party meeting this Friday to review the COVID-19 situation in India, according to reports.

Applying for Covishield's emergency approval in 2 weeks: SII

28 Nov 2020

Technology
Applying for Covishield's emergency approval in 2 weeks: SII

The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.

PM to visit three cities to review coronavirus vaccine development

28 Nov 2020

India
PM to visit three cities to review coronavirus vaccine development

Prime Minister Narendra Modi will visit three cities today to review the coronavirus vaccine development and manufacturing process, his office revealed.

Can launch 100 million vaccine doses by January-February, says Poonawalla

23 Nov 2020

Technology
Can launch 100 million vaccine doses by January-February, says Poonawalla

The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.

Oxford vaccine to be available by April 2021 in India

20 Nov 2020

India
Oxford vaccine to be available by April 2021 in India

Pune-based Serum Institute of India, which has partnered with Oxford University and British pharma giant AstraZeneca, plans to seek an emergency approval from the government of India next month, for providing the coronavirus vaccine to "corona warriors" and the elderly.

India to get 10cr COVID-19 vaccine doses by December: SII

14 Nov 2020

Technology
India to get 10cr COVID-19 vaccine doses by December: SII

The Serum Institute of India is hoping to produce 100 million (10 crore) doses of AstraZeneca and Oxford University's COVID-19 vaccine, CEO Adar Poonawalla said.

COVISHIELD vaccine could be realistic solution to COVID-19 pandemic: ICMR

12 Nov 2020

India
COVISHIELD vaccine could be realistic solution to COVID-19 pandemic: ICMR

The Indian Council of Medical Research (ICMR) and Pune-based Serum Institute of India (SII) on Thursday announced the completion of enrollment of participants to the Phase-3 clinical trials for the potential COVID-19 vaccine COVISHIELD in India.

Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February

08 Nov 2020

Technology
Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February

Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.

Bharat Biotech's coronavirus vaccine could be out by February 2021

05 Nov 2020

Technology
Bharat Biotech's coronavirus vaccine could be out by February 2021

The coronavirus vaccine being developed by Bharat Biotech could be launched by February, months earlier than expected, an official from the Indian Council of Medical Research (ICMR), told Reuters on Thursday.

Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla

05 Nov 2020

India
Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla

Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.

Vaccine tracker: Covishield expected by December; Moderna readies for launch

01 Nov 2020

Technology
Vaccine tracker: Covishield expected by December; Moderna readies for launch

It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.

Oxford's coronavirus vaccine could be available by December: Adar Poonawalla

29 Oct 2020

India
Oxford's coronavirus vaccine could be available by December: Adar Poonawalla

In a welcome piece of development, Serum Institute of India's CEO Adar Poonawalla said on Wednesday that the coronavirus vaccine, being developed by Oxford University, could be available for use in India by December 2020.

Coronavirus: India reserves Rs. 50,000 crore for vaccinating entire country

22 Oct 2020

India
Coronavirus: India reserves Rs. 50,000 crore for vaccinating entire country

The Indian government has reportedly set aside Rs. 50,000 crore to ensure that the COVID-19 vaccine reaches the entire country.

India to play crucial role in COVID-19 vaccine process

20 Oct 2020

Technology
India to play crucial role in COVID-19 vaccine process

As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.

PM's vaccine arrangements will take care of all: Adar Poonawalla

27 Sep 2020

India
PM's vaccine arrangements will take care of all: Adar Poonawalla

As India's COVID-19 vaccine strategy becomes a point of debate, Adar Poonawalla has expressed confidence over Prime Minister Narendra Modi's vision to protect Indian citizens from the ongoing pandemic.